Unnecessary thyroid nodule biopsy rates under four ultrasound risk stratification systems: a systematic review and meta-analysis
Objectives To summarize and compare unnecessary biopsy rates and diagnostic
performance in the examination of thyroid nodules according to four representative US …
performance in the examination of thyroid nodules according to four representative US …
Trends in thyroid cancer incidence and mortality in the United States, 1974-2013
H Lim, SS Devesa, JA Sosa, D Check, CM Kitahara - Jama, 2017 - jamanetwork.com
Importance Thyroid cancer incidence has increased substantially in the United States over
the last 4 decades, driven largely by increases in papillary thyroid cancer. It is unclear …
the last 4 decades, driven largely by increases in papillary thyroid cancer. It is unclear …
Thyroid cancer surgery guidelines in an era of de-escalation
KJ Kovatch, CW Hoban, AG Shuman - European Journal of Surgical …, 2018 - Elsevier
Well-differentiated thyroid carcinoma has seen a tremendous rise in global incidence over
the past three decades, largely owing to widespread screening and identification of small …
the past three decades, largely owing to widespread screening and identification of small …
Diagnostic performance of practice guidelines for thyroid nodules: thyroid nodule size versus biopsy rates
SM Ha, JH Baek, DG Na, CH Suh, SR Chung, YJ Choi… - Radiology, 2019 - pubs.rsna.org
Background The diagnostic performance and unnecessary biopsy rates for evaluation of
thyroid nodules varies among the current society guidelines. We hypothesized that …
thyroid nodules varies among the current society guidelines. We hypothesized that …
[HTML][HTML] Nomogram for predicting central lymph node metastasis in papillary thyroid cancer: a retrospective cohort study of two clinical centers
Z Yang, Y Heng, J Lin, C Lu, D Yu… - Cancer Research and …, 2020 - synapse.koreamed.org
Purpose Central lymph node metastasis (CNM) are highly prevalent but hard to detect
preoperatively in papillary thyroid carcinoma (PTC) patients, while the significance of …
preoperatively in papillary thyroid carcinoma (PTC) patients, while the significance of …
BRAF V600E Mutation-Assisted Risk Stratification of Solitary Intrathyroidal Papillary Thyroid Cancer for Precision Treatment
Background Precise risk stratification-based treatment of solitary intrathyroidal papillary
thyroid cancer (SI-PTC) that is larger than 1.0 cm and 4.0 cm or less is undefined. Methods A …
thyroid cancer (SI-PTC) that is larger than 1.0 cm and 4.0 cm or less is undefined. Methods A …
Insurance-based disparities in guideline-concordant thyroid cancer care in the era of de-escalation
SP Ginzberg, JMS Ballester, CJ Wirtalla… - Journal of Surgical …, 2023 - Elsevier
Introduction Prior studies have demonstrated insurance-based disparities in the treatment of
well-differentiated thyroid cancer. However, it remains unclear whether these disparities …
well-differentiated thyroid cancer. However, it remains unclear whether these disparities …
Selected controversies of radioiodine imaging and therapy in differentiated thyroid cancer
D Van Nostrand - Endocrinology and Metabolism Clinics, 2017 - endo.theclinics.com
Radioiodine is important in the diagnostic and therapeutic armamentarium of differentiated
thyroid cancer (DTC); however, many controversies persist. This article addresses some of …
thyroid cancer (DTC); however, many controversies persist. This article addresses some of …
European experience with the Afirma Gene Expression Classifier for indeterminate thyroid nodules: A clinical utility study in the Netherlands
I Lončar, EFS van Velsen, ET Massolt… - Head & …, 2023 - Wiley Online Library
Abstract Background The Gene Expression Classifier (GEC) and Genomic Sequencing
Classifier (GSC) were developed to improve risk stratification of indeterminate nodules. Our …
Classifier (GSC) were developed to improve risk stratification of indeterminate nodules. Our …
Outcome prediction with the revised American joint committee on cancer staging system and American thyroid association guidelines for thyroid cancer
Background Several staging systems have been developed to predict the risk of mortality in
patients with differentiated thyroid cancer (DTC). However, none of them have been shown …
patients with differentiated thyroid cancer (DTC). However, none of them have been shown …